Share ownership Vimian Group AB

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 17/07/2026 pm IST			5-day change	1st Jan Change
33.75 ^SEK	+3.69%		+10.84%	+11.24%

17/07	Vimian Group AB, Q2 2026 Earnings Call, Jul 17, 2026
17/07	Vimian increased operating profit more than expected	FW

Share class: Vimian Group AB

	Vote	Quantity	Free-Float	Total Float
Stock A	0	8,73,728	0	34.72 %
Stock B	0	14,85,532	0
Stock C	0	9,38,605	0
Stock D	1	52,59,64,772	18,37,56,593 ( 34.94 %)

Major shareholders: Vimian Group AB

Name	Stocks	%	Valuation
Fidelio Capital AB 59.62 %	31,35,82,999	59.62 %	946 M kr
Prg Investment Holdings 3.394 %	1,78,50,843	3.394 %	54 M kr
Grandeur Peak Global Advisors LLC 2.319 %	1,21,98,023	2.319 %	37 M kr
Anicom Gestion 1.901 %	1,00,00,000	1.901 %	30 M kr
Investering & Tryghed AS 1.583 %	83,25,742	1.583 %	25 M kr
Finn Pharmaceuticals Pty Ltd. 1.542 %	81,12,281	1.542 %	24 M kr
Case Kapitalförvaltning AB 0.8183 %	43,04,099	0.8183 %	13 M kr
Financière de l'Échiquier SA 0.7345 %	38,63,304	0.7345 %	12 M kr
Sven Johan Magnus Kjellberg 0.4831 %	25,41,040	0.4831 %	8 M kr
Cliens Kapitalförvaltning AB 0.3232 %	17,00,000	0.3232 %	5 M kr
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	64.79%
Others	8.42%
Individuals	0.96%
Unknown	25.83%

Based on 1000 largest holdings

Geographical origin of shareholders

Sweden	62.55%
United States	5.71%
Belgium	1.9%
Denmark	1.58%
Individuals	0.96%
France	0.78%
Finland	0.44%
Germany	0.17%
Spain	0.06%
Ireland	0.01%
United Kingdom	0.01%

Based on 1000 largest holdings

Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

Employees

1,300

Sector

Pharmaceuticals

Calendar

Earnings release - Q3 2026

More about the company